(Q57842307)

José Manuel Bravo-San Pedro

4

object named as

Guido Kroemer

0 references

3

object named as

José Manuel Bravo-San Pedro

0 references

author name string

Paolo Ettore Porporato

1

0 references

Nicoletta Filigheddu

Creative Commons Attribution 4.0 International

2

0 references

language of work or name

English

0 references

publication date

March 2018

0 references

1 March 2018

1 reference

12 October 2019

1 reference

12 October 2019

28

0 references

issue

3

0 references

page(s)

265-280

0 references

copyright license

1 reference

Europe PubMed Central

Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?

12 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Natural and therapy-induced immunosurveillance in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Metabolic dysregulation in monogenic disorders and cancer - finding method in madness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Cancer metabolism in space and time: Beyond the Warburg effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Elements of cancer immunity and the cancer-immune set point

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

21 January 2018

Mitochondria and Cancer.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

21 January 2018

Mitochondria and cancer

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Disease tolerance and immunity in host protection against infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Understanding the Warburg effect: the metabolic requirements of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

THE METABOLISM OF TUMORS IN THE BODY

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

On respiratory impairment in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

On the Origin of Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Mitochondrial control of nuclear apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Targeting mitochondria for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Reductive glutamine metabolism is a function of the α-ketoglutarate to citrate ratio in cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Cancer metabolism: a therapeutic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Metabolic targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Metabolic reprogramming in the tumour microenvironment: a hallmark shared by cancer cells and T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Mouse models in oncoimmunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Defects in mitochondrial metabolism and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Mitochondrial Permeability Transition: New Findings and Persisting Uncertainties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Ambient oxygen promotes tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Mitochondrial metabolism and energy sensing in tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Molecular definitions of autophagy and related processes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

U2AF35(S34F) Promotes Transformation by Directing Aberrant ATG7 Pre-mRNA 3' End Formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Autophagy in malignant transformation and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

p53 status determines the role of autophagy in pancreatic tumour development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Fanconi Anemia Proteins Function in Mitophagy and Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Mutant KRas-Induced Mitochondrial Oxidative Stress in Acinar Cells Upregulates EGFR Signaling to Drive Formation of Pancreatic Precancerous Lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Altered metabolite levels in cancer: implications for tumour biology and cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

IDH mutation impairs histone demethylation and results in a block to cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Succination of Keap1 and activation of Nrf2-dependent antioxidant pathways in FH-deficient papillary renal cell carcinoma type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Absence of Neurofibromin Induces an Oncogenic Metabolic Switch via Mitochondrial ERK-Mediated Phosphorylation of the Chaperone TRAP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

The mitochondrial chaperone TRAP1 promotes neoplastic growth by inhibiting succinate dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

A metabolic switch controls intestinal differentiation downstream of Adenomatous polyposis coli (APC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Mitochondrial division is requisite to RAS-induced transformation and targeted by oncogenic MAPK pathway inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Erk2 phosphorylation of Drp1 promotes mitochondrial fission and MAPK-driven tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Mitochondrial control by DRP1 in brain tumor initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Senescent cells: an emerging target for diseases of ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Horizontal transfer of whole mitochondria restores tumorigenic potential in mitochondrial DNA-deficient cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Mitochondrial capture by a transmissible cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

A dual role for autophagy in a murine model of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

The Genomic Landscape of Renal Oncocytoma Identifies a Metabolic Barrier to Tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

An Essential Role of the Mitochondrial Electron Transport Chain in Cell Proliferation Is to Enable Aspartate Synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Supporting Aspartate Biosynthesis Is an Essential Function of Respiration in Proliferating Cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Hypoxic regulation of glutamine metabolism through HIF1 and SIAH2 supports lipid synthesis that is necessary for tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

From Krebs to clinic: glutamine metabolism to cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Acetate is a bioenergetic substrate for human glioblastoma and brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Serine Metabolism Supports the Methionine Cycle and DNA/RNA Methylation through De Novo ATP Synthesis in Cancer Cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Catabolism of exogenous lactate reveals it as a legitimate metabolic substrate in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Quantitative flux analysis reveals folate-dependent NADPH production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Acidosis Drives the Reprogramming of Fatty Acid Metabolism in Cancer Cells through Changes in Mitochondrial and Histone Acetylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Acetyl coenzyme A: a central metabolite and second messenger

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

The multifaceted roles of fatty acid synthesis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

ATP-citrate lyase links cellular metabolism to histone acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Regulation of autophagy by cytosolic acetyl-coenzyme A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

The Emerging Hallmarks of Cancer Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

ATP-Citrate Lyase Controls a Glucose-to-Acetate Metabolic Switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Serine catabolism regulates mitochondrial redox control during hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Differential Glutamate Metabolism in Proliferating and Quiescent Mammary Epithelial Cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Metabolic Rewiring by Oncogenic BRAF V600E Links Ketogenesis Pathway to BRAF-MEK1 Signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Prevention of Dietary-Fat-Fueled Ketogenesis Attenuates BRAF V600E Tumor Growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Physiological roles of mitochondrial reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

mtDNA mutations increase tumorigenicity in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Redox Homeostasis and Mitochondrial Dynamics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

PGC-1α supports glutamine metabolism in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

The mitochondrial ATPase inhibitory factor 1 triggers a ROS-mediated retrograde prosurvival and proliferative response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Molecular mechanisms of cell death: central implication of ATP synthase in mitochondrial permeability transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Synthetic lethal metabolic targeting of cellular senescence in cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Cell biology. Metabolic control of cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Methyl jasmonate binds to and detaches mitochondria-bound hexokinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Glucose metabolism inhibits apoptosis in neurons and cancer cells by redox inactivation of cytochrome c.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Reductive carboxylation supports redox homeostasis during anchorage-independent growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

The Warburg effect suppresses oxidative stress induced apoptosis in a yeast model for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Ischaemic conditioning and reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Unraveling the truth about antioxidants: mitohormesis explains ROS-induced health benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

SCaMC-1 promotes cancer cell survival by desensitizing mitochondrial permeability transition via ATP/ADP-mediated matrix Ca(2+) buffering

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Mitochondrial elongation-mediated glucose metabolism reprogramming is essential for tumour cell survival during energy stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

During autophagy mitochondria elongate, are spared from degradation and sustain cell viability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Metabolic Heterogeneity in Human Lung Tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Tumorigenesis: it takes a village

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Environment Impacts the Metabolic Dependencies of Ras-Driven Non-Small Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Cancer stem cells: The root of tumor recurrence and metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Energy metabolism characterization of a novel cancer stem cell-like line 3AB-OS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Sub-sets of cancer stem cells differ intrinsically in their patterns of oxygen metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Metabolic symbiosis in cancer: refocusing the Warburg lens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Energy transfer in "parasitic" cancer metabolism: mitochondria are the powerhouse and Achilles' heel of tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Adipocytes activate mitochondrial fatty acid oxidation and autophagy to promote tumor growth in colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Control of Metastasis by NK Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Mitochondrial metabolites: undercover signalling molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Loss of the novel mitochondrial protein FAM210B promotes metastasis via PDK4-dependent metabolic reprogramming.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

A neuronal network of mitochondrial dynamics regulates metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Survivin promotes oxidative phosphorylation, subcellular mitochondrial repositioning, and tumor cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

PI3K therapy reprograms mitochondrial trafficking to fuel tumor cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Mitophagy defects arising from BNip3 loss promote mammary tumor progression to metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

A mitochondrial switch promotes tumor metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

HIF-1α stabilization by mitochondrial ROS promotes Met-dependent invasive growth and vasculogenic mimicry in melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Fatty Acid Oxidation-Driven Src Links Mitochondrial Energy Reprogramming and Oncogenic Properties in Triple-Negative Breast Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Tissue-specific and convergent metabolic transformation of cancer correlates with metastatic potential and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

SIRT4 inhibits malignancy progression of NSCLCs, through mitochondrial dynamics mediated by the ERK-Drp1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

MCU-dependent mitochondrial Ca(2+) inhibits NAD(+)/SIRT3/SOD2 pathway to promote ROS production and metastasis of HCC cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Oxidative stress inhibits distant metastasis by human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Antioxidants can increase melanoma metastasis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Antioxidants accelerate lung cancer progression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Molecular mechanisms of cisplatin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Radiation responses and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Heterogeneous mechanisms of primary and acquired resistance to third-generation EGFR inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Regulated necrosis: disease relevance and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Necroptosis: Mechanisms and Relevance to Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Metabolic control of autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

(R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Disruption of mitochondrial electron transport chain function potentiates the pro-apoptotic effects of MAPK inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Metabolic shifts in residual breast cancer drive tumor recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Adaptive mitochondrial reprogramming and resistance to PI3K therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

ERRα-Regulated Lactate Metabolism Contributes to Resistance to Targeted Therapies in Breast Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

SIRT1/PGC1α-Dependent Increase in Oxidative Phosphorylation Supports Chemotherapy Resistance of Colon Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Inhibition of glucose-6-phosphate dehydrogenase sensitizes cisplatin-resistant cells to death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Manipulation of tumor oxygenation and radiosensitivity through modification of cell respiration. A critical review of approaches and imaging biomarkers for therapeutic guidance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Resistance to Antiangiogenic Therapies by Metabolic Symbiosis in Renal Cell Carcinoma PDX Models and Patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Targeting Metabolic Symbiosis to Overcome Resistance to Anti-angiogenic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Metabolic Symbiosis Enables Adaptive Resistance to Anti-angiogenic Therapy that Is Dependent on mTOR Signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

MHC-I modulation due to changes in tumor cell metabolism regulates tumor sensitivity to CTL and NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Mitochondria: master regulators of danger signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Metabolic Instruction of Immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Immunogenic cell death in cancer and infectious disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Molecular mechanisms of ATP secretion during immunogenic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Caloric restriction augments radiation efficacy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Caloric restriction coupled with radiation decreases metastatic burden in triple negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Circulating mitochondrial DAMPs cause inflammatory responses to injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Apoptotic caspases suppress mtDNA-induced STING-mediated type I IFN production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Apoptotic caspases prevent the induction of type I interferons by mitochondrial DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Caspases Connect Cell-Death Signaling to Organismal Homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Mitochondria in the regulation of innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Memory CD8(+) T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Autophagy is a critical regulator of memory CD8(+) T cell formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Mitochondrial complex I activity suppresses inflammation and enhances bone resorption by shifting macrophage-osteoclast polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Programmed mitophagy is essential for the glycolytic switch during cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Reshaping of Human Macrophage Polarization through Modulation of Glucose Catabolic Pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Macrophage Metabolism Controls Tumor Blood Vessel Morphogenesis and Metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Succinate Dehydrogenase Supports Metabolic Repurposing of Mitochondria to Drive Inflammatory Macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Inflammasomes in carcinogenesis and anticancer immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155

Mammary adipocytes stimulate breast cancer invasion through metabolic remodeling of tumor cells.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5835768

Linking metabolic reprogramming to therapy resistance in cancer

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5835768

The Reactive Oxygen Species in Macrophage Polarization: Reflecting Its Dual Role in Progression and Treatment of Human Diseases

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5835768

Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5835768

Reductive carboxylation supports growth in tumour cells with defective mitochondria.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5835768

Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5835768

Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5835768

Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5835768

Tumor-forming ability in athymic nude mice of human cell lines devoid of mitochondrial DNA.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5835768

Commentary on the biological self: Toward a "Biological Ego". From Garrod's "chemical individuality" to Burnet's "self".

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5835768

The spectrum of T cell metabolism in health and disease

30 November 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2017.155